ACE and Arrhythmia: Another article provides comparable evidence, in which the study concluded that ICDs, in addition to the use of angiotensin-converting enzyme (ACE inhibitors) and beta-blockers, in patients with severe, non-ischemic dilated cardiomyopathy significantly reduced the risk of sudden death from arrhythmia [5].